Cited by 724PI3K/AKT/mTOR signaling in cancerTuberous Sclerosis Complex ResearchMetabolism, Diabetes, and Cancer

The DOI matches its Crossref record; 34 of the 35 references it cites were found in a registry or an index.

A complex interplay between Akt, TSC2 and the two mTOR complexes

Open access

Huang, Jingxiang, Manning, Brendan D.·2009·Biochemical Society Transactions

Open this paper in CoChat — free account

Abstract

Akt/PKB (protein kinase B) both regulates and is regulated by the TSC (tuberous sclerosis complex) 1–TSC2 complex. Downstream of PI3K (phosphoinositide 3-kinase), Akt phosphorylates TSC2 directly on multiple sites. Although the molecular mechanism is not well understood, these phosphorylation events relieve the inhibitory effects of the TSC1–TSC2 complex on Rheb and mTORC1 [mTOR (mammalian target of rapamycin) complex] 1, thereby activating mTORC1 in response to growth factors. Through negative-feedback mechanisms, mTORC1 activity inhibits growth factor stimulation of PI3K. This is particularly evident in cells and tumours lacking the TSC1–TSC2 complex, where Akt signalling is severely attenuated due, at least in part, to constitutive activation of mTORC1. An additional level of complexity in the relationship between Akt and the TSC1–TSC2 complex has recently been uncovered. The growth-factor-stimulated kinase activity of mTORC2 [also known as the mTOR–rictor (rapamycin-insensitive companion of mTOR) complex], which normally enhances Akt signalling by phosphorylating its hydrophobic motif (Ser473), was found to be defective in cells lacking the TSC1–TSC2 complex. This effect on mTORC2 can be separated from the inhibitory effects of the TSC1–TSC2 complex on Rheb and mTORC1. The present review discusses our current understanding of the increasingly complex functional interactions between Akt, the TSC1–TSC2 complex and mTOR, which are fundamentally important players in a large variety of human diseases.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1042/bst0370217

Cites

34 of 34 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex
Sarbassov, D. D., Guertin, D. A., Ali, S. M., & Sabatini, D. M. (2005) · Science · doi:10.1126/science.1106148 · Cited by 6,216
AKT/PKB signaling: navigating downstream
Manning, B. D., & Cantley, L. C. (2007) · Cell · doi:10.1016/j.cell.2007.06.009 · Cited by 6,115
Self-citation
TOR signaling in growth and metabolism
Wullschleger, S., Loewith, R., & Hall, M. N. (2006) · Cell · doi:10.1016/j.cell.2006.01.016 · Cited by 5,787
Upstream and downstream of mTOR
Hay, N., & Sonenberg, N. (2004) · Genes & Development · doi:10.1101/gad.1212704 · Cited by 4,181
The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism
Engelman, J. A., Luo, J., & Cantley, L. C. (2006) · Nature Reviews Genetics · doi:10.1038/nrg1879 · Cited by 3,330
TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling
Inoki, K., Li, Y., Zhu, T., Wu, J., & Guan, K.-L. (2002) · Nature Cell Biology · doi:10.1038/ncb839 · Cited by 3,083
Mechanism of activation of protein kinase B by insulin and IGF‐1.
Alessi, D. R., Andjelković, M., Caudwell, B., Cron, P. D., MORRICE, N. A., Cohen, P., & Hemmings, B. A. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb01045.x · Cited by 3,014
Characterization of a 3-phosphoinositide-dependent protein kinase which phosphorylates and activates protein kinase Bα
Alessi, D. R., James, S. R., Downes, C. P., Holmes, A. B., Gaffney, P. R. J., Reese, C. B., & Cohen, P. (1997) · Current Biology · doi:10.1016/s0960-9822(06)00122-9 · Cited by 2,874
Rictor, a Novel Binding Partner of mTOR, Defines a Rapamycin-Insensitive and Raptor-Independent Pathway that Regulates the Cytoskeleton
Sarbassov, D. D., Ali, S. M., Kim, D.-H., Guertin, D. A., Latek, R. R., Erdjument-Bromage, H., Tempst, P., & Sabatini, D. M. (2004) · Current Biology · doi:10.1016/j.cub.2004.06.054 · Cited by 2,665
Prolonged Rapamycin Treatment Inhibits mTORC2 Assembly and Akt/PKB
Sarbassov, D. D., Ali, S. M., Sengupta, S., Sheen, J.-H., Hsu, P. P., Bagley, A. F., Markhard, A. L., & Sabatini, D. M. (2006) · Molecular Cell · doi:10.1016/j.molcel.2006.03.029 · Cited by 2,365

Show all 35 references

Sorted by citations

Items 401–500 of 723

Supplementation Strategies for Strength and Power Athletes: Carbohydrate, Protein, and Amino Acid Ingestion
Bird, S. P., Nienhuis, M. B., Biagioli, B., Pauw, K. D., & MEEUSEN, R. R. (2024) · Nutrients · doi:10.3390/nu16121886 · Cited by 27
mTOR Signaling in Aquaculture Animals: A Central Nutrient‐Sensing Hub Orchestrating Growth, Metabolism, Health and Quality
Liu, Y., Mai, K., & Zhang, W. (2025) · Reviews in Aquaculture · doi:10.1111/raq.70068 · Cited by 23
Spliceosomic dysregulation unveils NOVA1 as a candidate actionable therapeutic target in pancreatic neuroendocrine tumors
Pedraza‐Arévalo, S., Alors‐Pérez, E., Blázquez‐Encinas, R., Herrera-Martínez, A. D., Jiménez‐Vacas, J. M., Fuentes-Fayos, A. C., Reyes, Ó., Ventura, S., Sánchez‐Sánchez, R., Ortega-Salas, R. M., et al. (2022) · Translational research · doi:10.1016/j.trsl.2022.07.005 · Cited by 21
mTOR and its tight regulation for iNKT cell development and effector function
Yang, W., Gorentla, B. K., Zhong, X., & Shin, J. (2015) · Molecular Immunology · doi:10.1016/j.molimm.2015.07.022 · Cited by 23
Localization of avβ6 integrin-TGF-β1/Smad3, mTOR and PPARγ in experimental colorectal fibrosis
Latella, G., Vetuschi, A., Sferra, R., Speca, S., & Gaudio, E. (2013) · European Journal of Histochemistry · doi:10.4081/ejh.2013.e40 · Cited by 23
Renal tumours in a Tsc1+/– mouse model show epigenetic suppression of organic cation transporters Slc22a1, Slc22a2 and Slc22a3, and do not respond to metformin
Yang, J., Kalogerou, M., Gallacher, J., Sampson, J. R., & Shen, M. H. (2012) · European Journal of Cancer · doi:10.1016/j.ejca.2012.10.027 · Cited by 22
p53 promotes AKT and SP1-dependent metabolism through the pentose phosphate pathway that inhibits apoptosis in response to Nutlin-3a
Duan, L., Perez, R. E., Chen, L., Blatter, L. A., & Maki, C. G. (2017) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjx051 · Cited by 24
mTOR Signaling in Lymphangioleiomyomatosis
Kristof, A. S. (2010) · Lymphatic Research and Biology · doi:10.1089/lrb.2009.0019 · Cited by 23
AIMTOR, a BRET biosensor for live imaging, reveals subcellular mTOR signaling and dysfunctions
Bouquier, N., Moutin, E., Tintignac, L. A. J., Reverbel, A., Jublanc, É., Sinnreich, M., Chastagnier, Y., Avérous, J., Fafournoux, P., Verpelli, C., et al. (2020) · BMC Biology · doi:10.1186/s12915-020-00790-8 · Cited by 23
Hypoxia‐inducible factors – regulation, role and comparative aspects in tumourigenesis
Hansen, A. E., Kristensen, A. T., Law, I. G., Jørgensen, J. T., & Engelholm, S. A. (2010) · Veterinary and Comparative Oncology · doi:10.1111/j.1476-5829.2010.00233.x · Cited by 23
Impaired Cellular Energy Metabolism Contributes to Duck-Enteritis-Virus-Induced Autophagy via the AMPK–TSC2–MTOR Signaling Pathway
Yin, H., Zhao, L., Li, S., Xu, L., Wang, Y., & Chen, H. (2017) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2017.00423 · Cited by 22
PI3K/mTORC1/2 inhibitor PQR309 inhibits proliferation and induces apoptosis in human glioblastoma cells
Yang, K., Tang, X., Xu, F., Liu, J., Tan, Y., Gao, L., Sun, Q., Ding, X., Liu, B., & Chen, Q. (2020) · Oncology Reports · doi:10.3892/or.2020.7472 · Cited by 22
Reactive oxygen species induce cell death via Akt signaling in rat osteoblast-like cell line ROS 17/2.8
Zhang, B., Xie, Q., Quan, Y., Pan, X., & Liao, D. (2013) · Toxicology and Industrial Health · doi:10.1177/0748233713491801 · Cited by 22
Regulation of the mTOR-Rac1 axis in platelet function
Aslan, J. E., & McCarty, O. J. T. (2012) · Small GTPases · doi:10.4161/sgtp.19137 · Cited by 22
Major Physiological Signaling Pathways in the Regulation of Cell Proliferation and Survival
Tang, H., & Xue, G. (2017) · Handbook of experimental pharmacology · doi:10.1007/164_2017_4 · Cited by 22
The role of TSC1 and TSC2 proteins in neuronal axons
Karalis, V., Wood, D., Teaney, N. A., & Sahin, M. (2024) · Molecular Psychiatry · doi:10.1038/s41380-023-02402-7 · Cited by 21
Mouse hippocampal phosphorylation footprint induced by generalized seizures: Focus on ERK, mTORC1 and Akt/GSK-3 pathways
Gangarossa, G., Sakkaki, S., Lory, P., & Valjent, E. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2015.10.051 · Cited by 21
The Role and Regulation of mTOR in T-Lymphocyte Function
O’Brien, T. F., & Zhong, X. (2012) · Archivum Immunologiae et Therapiae Experimentalis · doi:10.1007/s00005-012-0171-4 · Cited by 22
mTOR inhibitor rapamycin suppresses striatal post-ischemic LTP
Ghiglieri, V., Pendolino, V., Bagetta, V., Sgobio, C., Calabresi, P., & Picconi, B. (2010) · Experimental Neurology · doi:10.1016/j.expneurol.2010.09.012 · Cited by 21
Relative Expression Levels Rather Than Specific Activity Plays the Major Role in DeterminingIn VivoAKT Isoform Substrate Specificity
Lee, R. S., House, C. M., Cristiano, B. E., Hannan, R. D., Pearson, R. B., & Hannan, K. M. (2011) · Enzyme Research · doi:10.4061/2011/720985 · Cited by 20
GSK3β inactivation in podocytes results in decreased phosphorylation of p70S6Kaccompanied by cytoskeletal rearrangements and inhibited motility
George, B., Vollenbröker, B., Saleem, M. A., Huber, T. B., Pavenstädt, H., & Weide, T. (2011) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00373.2010 · Cited by 21
Polybrominated diphenyl ether congener, BDE-47, impairs insulin sensitivity in mice with liver-specific Pten deficiency
McIntyre, R. L., Kenerson, H. L., Subramanian, S., Wang, S. A., Kazami, M., Stapleton, H. M., & Yeung, R. S. W. (2015) · BMC Obesity · doi:10.1186/s40608-014-0031-3 · Cited by 21
Rapamycin reverses paraquat-induced acute lung injury in a rat model through inhibition of NFκB activation.
Chen, D., Ma, T., Liu, X., Yang, C. C., & Liu, Z. (2015) · PubMed Central · Cited by 21
Agmatine potentiates neuroprotective effects of subthreshold concentrations of ketamine via mTOR/S6 kinase signaling pathway
Tavares, M. K., dos Reis, S., Platt, N., Heinrich, I. A., Wolin, I. A. V., Leal, R. B., Kaster, M. P., Rodrigues, A. L. S., & Freitas, A. E. (2018) · Neurochemistry International · doi:10.1016/j.neuint.2018.05.006 · Cited by 21
Lanreotide Induces Cytokine Modulation in Intestinal Neuroendocrine Tumors and Overcomes Resistance to Everolimus
Sciammarella, C., Luce, A., Riccardi, F., Mocerino, C., Modica, R., Berretta, M., Misso, G., Cossu, A. M., Colao, A. A. L., Vitale, G., et al. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.01047 · Cited by 21
Bengalin initiates autophagic cell death through ERK–MAPK pathway following suppression of apoptosis in human leukemic U937 cells
Gupta, S. D., Halder, B., Gomes, A., & Gomes, A. (2013) · Life Sciences · doi:10.1016/j.lfs.2013.06.022 · Cited by 21
Metformin and the PI3K/AKT signaling pathway: implications for cancer, cardiovascular, and central nervous system diseases
Ahmadabad, H. A., Panah, S. M., Ghasemnejad‐Berenji, H., Ghojavand, S., Ghasemnejad‐Berenji, M., & Khezri, M. R. (2024) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-024-03358-3 · Cited by 20
Targeting c-MYC has a key role in hepatocellular carcinoma therapy
Dai, P., & Wang, L. (2025) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2025.104786 · Cited by 22
Impact of keratin intermediate filaments on insulin‐mediated glucose metabolism regulation in the liver and disease association
Roux, A., Gilbert, S., Loranger, A., & Marceau, N. (2015) · The FASEB Journal · doi:10.1096/fj.15-277905 · Cited by 20
Molecular regulation of autophagy in a pro-inflammatory tumour microenvironment: New insight into the role of serum amyloid A
du Plessis, M., Davis, T., Loos, B., Pretorius, E., de Villiers, W. J. S., & Engelbrecht, A. (2021) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2021.01.007 · Cited by 20
Signaling Pathways in Inflammation and Cardiovascular Diseases: An Update of Therapeutic Strategies
Cucu, I. (2022) · Immuno · doi:10.3390/immuno2040039 · Cited by 23
Picornavirus infection enhances aspartate by the SLC38A8 transporter to promote viral replication
Liu, H., Zhu, Z., Xue, Q., Yang, F., Cao, W., Xue, Z., Liu, X., & Zheng, H. (2023) · PLoS Pathogens · doi:10.1371/journal.ppat.1011126 · Cited by 20
Cyclin G Functions as a Positive Regulator of Growth and Metabolism in Drosophila
Fischer, P., Rosa, M. K. L., Schulz, A., Preiss, A., & Nagel, A. C. (2015) · PLoS Genetics · doi:10.1371/journal.pgen.1005440 · Cited by 20
PI3K/Akt/mTOR, a Pathway Less Recognized for Staphylococcal Superantigen-Induced Toxicity
Krakauer, T. (2012) · Toxins · doi:10.3390/toxins4111343 · Cited by 20
mTOR, la cible fonctionnelle de la rapamycine
Julien, L.-A., & Roux, P. P. (2010) · médecine/sciences · doi:10.1051/medsci/201026121056 · Cited by 27
Rapamycin inhibits hydrogen peroxide-induced loss of vascular contractility
Gao, G., Li, J., Li, Y., Li, D., Wang, Y., Wang, L., Tang, X. D., Walsh, M. P., Gui, Y., & Zheng, X. (2011) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01084.2010 · Cited by 20
Integrated actions of mTOR complexes 1 and 2 for growth and development of Dictyostelium
Jaiswal, P., Majithia, A. R., Rösel, D., Liao, X., Khurana, T., & Kimmel, A. R. (2019) · The International Journal of Developmental Biology · doi:10.1387/ijdb.190245ak · Cited by 18
JNK Contributes to the Tumorigenic Potential of Human Cholangiocarcinoma Cells through the mTOR Pathway Regulated GRP78 Induction
Feng, C., He, K., Zhang, C., Su, S., Li, B., Li, Y., Duan, C.-Y., Chen, S., Chen, R., Liu, Y., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0090388 · Cited by 19
Retracted
Increased Mammalian Target of Rapamycin Complex 2 Signaling Promotes Age-Related Decline in CD4 T Cell Signaling and Function
Perkey, E., Fingar, D. C., Miller, R. A., & Garcia, G. G. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1300750 · Cited by 20
An Introduction to Phosphoinositides
Maffucci, T. (2012) · Current topics in microbiology and immunology · doi:10.1007/978-94-007-5025-8_1 · Cited by 19
In vitro antiglioma action of indomethacin is mediated via AMP-activated protein kinase/mTOR complex 1 signalling pathway
Pantovic, A., Bošnjak, M., Arsikin, K. M., Kosić, M., Mandić, M., Ristic, B. Z., Tasić, J., Grujičić, D., Isaković, A., Micic, N., et al. (2016) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2016.12.007 · Cited by 19
Deletion of diacylglycerol kinase ε confers susceptibility to obesity via reduced lipolytic activity in murine adipocytes
Nakano, T., Seino, K., Wakabayashi, I., Stafforini, D. M., Topham, M. K., & Goto, K. (2018) · The FASEB Journal · doi:10.1096/fj.201701050r · Cited by 19
CD55 Is Essential for CD103+ Dendritic Cell Tolerogenic Responses that Protect against Autoimmunity
Strainic, M. G., Liu, J., An, F., Bailey, E., Esposito, A., Hamann, J., Heeger, P. S., & Medof, M. E. (2019) · American Journal Of Pathology · doi:10.1016/j.ajpath.2019.04.008 · Cited by 19
Modelling and analysis of an ensemble of eukaryotic translation initiation models
Nayak, S., Siddiqui, J. K., & Varner, J. D. (2011) · IET Systems Biology · doi:10.1049/iet-syb.2009.0065 · Cited by 20
Autophagy and polyphenol intervention strategy in aging
Gu, Y., & Han, J. (2022) · Trends in Food Science & Technology · doi:10.1016/j.tifs.2022.12.013 · Cited by 19
TSC2 regulates tumor susceptibility to TRAIL‐mediated T‐cell killing by orchestrating mTOR signaling
Lin, C., Traets, J. J. H., Vredevoogd, D. W., Visser, N. L., & Peeper, D. S. (2023) · The EMBO Journal · doi:10.15252/embj.2022111614 · Cited by 19
Recent advances in the development of inhibitors targeting KRAS-G12C and its related pathways
Zhao, D., Liu, Y., Yi, F., Zhao, X., & Lu, K. (2023) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2023.115698 · Cited by 18
mTOR is involved in 17β‐estradiol‐induced, cultured immature boar Sertoli cell proliferation via regulating the expression of SKP2, CCND1, and CCNE1
Yang, W., Wang, Y., Wang, Y., Zhang, J., Zhang, J., Lu, C., & Wang, X. (2015) · Molecular Reproduction and Development · doi:10.1002/mrd.22473 · Cited by 18
Latest progress on the molecular mechanisms of idiopathic pulmonary fibrosis
Fang, Y., Tian, J., Fan, Y., & Cao, P. (2020) · Molecular Biology Reports · doi:10.1007/s11033-020-06000-6 · Cited by 20
Candidate tumor suppressor B-cell translocation gene 3 impedes neoplastic progression by suppression of AKT
Cheng, Y.-C., Chen, P., Chiang, H.-Y., Suen, C.-S., Hwang, M., Lin, T.-Y., Yang, H.-C., Lin, W.-C., Lai, P.-L., & Shieh, S.-Y. (2015) · Cell Death and Disease · doi:10.1038/cddis.2014.550 · Cited by 19
Molecular mechanisms and functions of autophagy and the ubiq-uitin-proteasome pathway
Chen, K., Cheng, H., & Zhou, R. (2012) · Hereditas (Beijing) · doi:10.3724/sp.j.1005.2012.00005 · Cited by 19
Overexpression of PTEN may increase the effect of pemetrexed on A549 cells via inhibition of the PI3K/AKT/mTOR pathway and carbohydrate metabolism
Li, B., Zhang, J., Su, Y., Hou, Y., Wang, Z., Zhao, L., Sun, S., & Fu, H. (2019) · Molecular Medicine Reports · doi:10.3892/mmr.2019.10617 · Cited by 18
Activation of PPAR-α induces cell cycle arrest and inhibits transforming growth factor-β1 induction of smooth muscle cell phenotype in 10T1/2 mesenchymal cells
Lien, S.-C., Wei, S., Chang, S., Chang, M. D., Chang, J., & Chiu, J. (2013) · Cellular Signalling · doi:10.1016/j.cellsig.2013.01.021 · Cited by 18
Developmental regulation of the activation of translation initiation factors of skeletal muscle in response to feeding in horses
Wagner, A. L., & Urschel, K. L. (2012) · American Journal of Veterinary Research · doi:10.2460/ajvr.73.8.1241 · Cited by 17
Targeting Abnormal PI3K/AKT/mTOR Signaling in Intracerebral Hemorrhage: A Systematic Review on Potential Drug Targets and Influences of Signaling Modulators on Other Neurological Disorders
Mehan, S., Jadaun, K. S., Sharma, A., & Siddiqui, E. M. (2021) · Current Clinical Pharmacology · doi:10.2174/1574884716666210726110021 · Cited by 19
Inhibition of the PI3K/AKT/mTOR pathway in pancreatic cancer: is it a worthwhile endeavor?
Jarroudi, O. A., Chibani, H., Brahmi, S. A., & Said, A. (2024) · Therapeutic Advances in Medical Oncology · doi:10.1177/17588359241284911 · Cited by 18
http://www.cancertreatmentjournal.com/old-issues.php?journal=jctd&&v=3&&i=1&&y=2019&&m=January
Sarcar, B., Li, X., & Fleming, J. B. (2019) · Journal of Cancer Treatment and Diagnosis · doi:10.29245/2578-2967/2019/1.1165 · Cited by 16
Influenza A Virus NS1 Protein Suppresses JNK1-Dependent Autophagosome Formation Mediated by Rab11a Recycling Endosomes
Kuroki, T., Osari, S., Nagata, K., & Kawaguchi, A. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.03120 · Cited by 17
Efficacy of Dual Inhibition of Glycolysis and Glutaminolysis for Therapy of Renal Lesions in Tsc2+/− Mice
Jones, A. T., Narov, K., Yang, J. M., Sampson, J. R., & Shen, M. H. (2019) · Neoplasia · doi:10.1016/j.neo.2018.12.003 · Cited by 16
Viscera and muscle protein synthesis in neonatal pigs is increased more by intermittent bolus than by continuous feeding
El‐Kadi, S. W., Gazzaneo, M. C., Suryawan, A., Orellana, R. A., Torrazza, R. J. M., Srivastava, N., Kimball, S. R., Nguyen, H. V., Fiorotto, M. L., & Davis, T. A. (2013) · Pediatric Research · doi:10.1038/pr.2013.89 · Cited by 15
Mechanisms mediating the effects of alcohol and HIV anti-retroviral agents on mTORC1, mTORC2 and protein synthesis in myocytes
Hong‐Brown, L. Q. (2012) · World Journal of Biological Chemistry · doi:10.4331/wjbc.v3.i6.110 · Cited by 15
Activation of Mammalian Target of Rapamycin Mediates Rat Pain-Related Responses Induced by BmK I, a Sodium Channel-Specific Modulator
Jiang, F., Pang, X.-Y., Niu, Q.-S., Hua, L.-M., Cheng, M. L., & Ji, Y. (2013) · Molecular Pain · doi:10.1186/1744-8069-9-50 · Cited by 15
Targeting the mTOR Pathway in Tumor Malignancy
Cheng, H., Walls, M., Baxi, S. M., & Yin, M.-J. (2013) · Current Cancer Drug Targets · doi:10.2174/1568009611313030005 · Cited by 15
Role of the mTOR signalling pathway in salivary gland development
Sakai, M., Fukumoto, M., Ikai, K., Minagi, H. O., Inagaki, S., Kogo, M., & Sakai, T. (2019) · FEBS Journal · doi:10.1111/febs.14937 · Cited by 15
Transforming growth factor-β enhances matrix metalloproteinase-2 expression and activity through AKT in fibroblasts derived from angiofibromas in patients with tuberous sclerosis complex
Lee, C., Hong, C., Yu, S., Chen, G., & Yang, K. (2010) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2010.09971.x · Cited by 15
Vorinostat synergizes with ridaforolimus and abrogates the ridaforolimus-induced activation of AKT in synovial sarcoma cells
Morgan, S. S., & Cranmer, L. D. (2014) · BMC Research Notes · doi:10.1186/1756-0500-7-812 · Cited by 15
Uroguanylin modulates (Na++ K+)ATPase in a proximal tubule cell line: Interactions among the cGMP/protein kinase G, cAMP/protein kinase A, and mTOR pathways
Arnaud-Batista, F. J., Peruchetti, D. B., de Abreu, T. P., do Nascimento, N. R. F., Malnic, G., Fonteles, M. C., & Caruso‐Neves, C. (2016) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2016.04.012 · Cited by 15
Effects of Metformin and a Mammalian Target of Rapamycin (mTOR) ATPCompetitive Inhibitor on Targeted Metabolomics in Pancreatic Cancer Cell Line
Soliman, G. A. (2016) · Journal of Postgenomics Drug & Biomarker Development · doi:10.4172/2153-0769.1000183 · Cited by 15
11C-Labeled Pictilisib (GDC-0941) as a Molecular Tracer Targeting Phosphatidylinositol 3-Kinase (PI3K) for Breast Cancer Imaging
Han, N., Jiang, Y., Gai, Y., Liu, Q., Yuan, L., Wang, Y., Li, M., Zhang, Y., & Lan, X. (2019) · Contrast Media & Molecular Imaging · doi:10.1155/2019/1760184 · Cited by 15
Ginseng polysaccharide inhibits MDA‑MB‑231 cell proliferation by activating the inflammatory response
Zhou, H., Yan, Y., Zhang, X., Zhao, T., Xu, J., & Han, R. (2020) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2020.9359 · Cited by 15
Jaagsiekte Sheep Retrovirus Transformation in Madin-Darby Canine Kidney Epithelial Cell Three-Dimensional Culture
Johnson, C., Sanders, K., & Fan, H. (2010) · Journal of Virology · doi:10.1128/jvi.02323-09 · Cited by 15
Targeting NRF2 and FSP1 to Overcome Ferroptosis Resistance in TSC2-Deficient and Cancer Cells
Tahsin, T., McPhail, D. K., Champion, J. D., Alzahrani, M. A. M., Hilditch, M. L., Faris-Orr, A., Calver, B. L., Sexton, D. W., Cronin, J., Rivas, J. C. M., et al. (2025) · Cancers · doi:10.3390/cancers17162714 · Cited by 19
Regulation of TORC2 Function and Localization in Yeast
Emmerstorfer‐Augustin, A., & Thorner, J. W. (2023) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev-cellbio-011723-030346 · Cited by 15
17ß-Estradiol Regulates mTORC2 Sensitivity to Rapamycin in Adaptive Cardiac Remodeling
Kusch, A., Schmidt, M., Gürgen, D., Postpieszala, D., Catar, R. A., Hegner, B., Davidson, M. M., Mahmoodzadeh, S., & Dragun, D. (2015) · PLoS ONE · doi:10.1371/journal.pone.0123385 · Cited by 14
Urokinase-type plasminogen activator (uPA) is critical for progression of tuberous sclerosis complex 2 (TSC2)-deficient tumors
Stepanova, V. V., Дергилев, К. В., Holman, K. R., Parfyonova, Y. V., Цоколаева, З. И., Teter, M., Atochina‐Vasserman, E. N., Volgina, A., Zaitsev, S. V., Lewis, S. P., et al. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m117.799593 · Cited by 13
Preclinical Evaluation of a Fluorine-18 (18F)-Labeled Phosphatidylinositol 3-Kinase Inhibitor for Breast Cancer Imaging
Altine, B., Gai, Y., Han, N., Jiang, Y., Ji, H., Fang, H., Niyonkuru, A., Bakari, K. H., Arnous, M. M. R., Liu, Q., et al. (2019) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.9b00690 · Cited by 14
Vibration exercise decreases insulin resistance and modulates the insulin signaling pathway in a type 2 diabetic rat model.
Liu, Y., Liu, C., Lü, M., Tang, F., Hou, X., Yang, J., & Liu, T. (2015) · Europe PMC (PubMed Central) · Cited by 14
Revealing protein networks and gene-drug connectivity in cancer from direct information
Jiang, X., Martínez-Ledesma, E., & Morcos, F. (2017) · Scientific Reports · doi:10.1038/s41598-017-04001-3 · Cited by 14
Regulation of Age-related Decline by Transcription Factors and Their Crosstalk with the Epigenome
Zhou, X., Sen, I., Lin, X.-X., & Riedel, C. G. (2018) · Current Genomics · doi:10.2174/1389202919666180503125850 · Cited by 15
Metabolic Optimisation of Regulatory T Cells in Transplantation
Atif, M., Mohr, A., Conti, F., Scatton, O., Gorochov, G., & Miyara, M. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.02005 · Cited by 16
Of local translation control and lipid signaling in neurons
Moine, H., & Vitale, N. (2018) · Advances in Biological Regulation · doi:10.1016/j.jbior.2018.09.005 · Cited by 15
Why is NMNAT Protective against Neuronal Cell Death and Axon Degeneration, but Inhibitory of Axon Regeneration?
Tang, B. L. (2019) · Cells · doi:10.3390/cells8030267 · Cited by 14
Trehalose activates hepatic transcription factor EB (TFEB) but fails to ameliorate alcohol‐impaired TFEB and liver injury in mice
Chao, X., Wang, S., Yang, L., Ni, H., & Ding, W. (2021) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.14695 · Cited by 13
Assembly and Function of the Precursor B-Cell Receptor
Übelhart, R., Werner, M., & Jumaa, H. (2015) · Current topics in microbiology and immunology · doi:10.1007/82_2015_475 · Cited by 15
Okadaic acid induces Akt hyperphosphorylation and an oxidative stress-mediated cell death in serum starved SK-N-SH human neuroblastoma cells that are augmented by rapamycin
Edelstein, J., & Rockwell, P. (2012) · Neuroscience Letters · doi:10.1016/j.neulet.2012.10.052 · Cited by 13
Signalling mechanisms regulating phenotypic changes in breast cancer cells
Volinsky, N., McCarthy, C., von Kriegsheim, A., Šaban, N., Okada, M., Kölch, W., & Kholodenko, B. Ν. (2015) · Bioscience Reports · doi:10.1042/bsr20140172 · Cited by 13
Glucose deprivation in tuberous sclerosis complex-related tumors
Jiang, X., Kenerson, H. L., & Yeung, R. S. W. (2011) · Cell & Bioscience · doi:10.1186/2045-3701-1-34 · Cited by 13
The Role of Chemokines in Migration of Metastatic-like Lymphangioleiomyomatosis Cells
Pacheco–Rodriguez, G., & Moss, J. (2010) · Critical Reviews in Immunology · doi:10.1615/critrevimmunol.v30.i4.40 · Cited by 13
Signal integration in the (m)TORC1 growth pathway
Ramlaul, K., & Aylett, C. H. S. (2018) · Frontiers in Biology · doi:10.1007/s11515-018-1501-7 · Cited by 12
Progress and prospects of biomarker-based targeted therapy and immune checkpoint inhibitors in advanced gastric cancer
Zeng, Z., & Zhu, Q. C. (2024) · Frontiers in Oncology · doi:10.3389/fonc.2024.1382183 · Cited by 12
Rictor Is a Novel Regulator of TRAF6/TRAF3 in Osteoclasts
Xu, S., Li, S., Liu, X., Tan, K. W., Zhang, J., Li, K., Bai, X., & Zhang, Y. (2020) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.4398 · Cited by 12
Translational Aspects of the Mammalian Target of Rapamycin Complexes in Diabetic Nephropathy
Daher, A. A., Alkhansa, S., Azar, W. S., Rafeh, R. W., Ghadieh, H. E., & Eid, A. A. (2021) · Antioxidants and Redox Signaling · doi:10.1089/ars.2021.0217 · Cited by 12
A Vascular Model of Tsc1 Deficiency Accelerates Renal Tumor Formation with Accompanying Hemangiosarcomas
Leech, J. D., Lammers, S. H. T., Goldman, S., Auricchio, N., Bronson, R. T., Kwiatkowski, D. J., & Şahin, M. (2014) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-14-0178 · Cited by 12
Dominant-negative Dmp53 extends life span through the dTOR pathway in D. melanogaster
Bauer, J. H., Chang, C.-Y., Bae, G., Morris, S. N. S., & Helfand, S. L. (2010) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2010.01.007 · Cited by 13
T2 weighted MRI for assessing renal lesions in transgenic mouse models of tuberous sclerosis
Kalogerou, M., Zhang, Y., Yang, J., Garrahan, N. J., Paisey, S. J., Tokarczuk, P. F., Stewart, A., Gallacher, J., Sampson, J. R., & Shen, M. H. (2011) · European Journal of Radiology · doi:10.1016/j.ejrad.2011.06.054 · Cited by 12
Diet and Hygiene in Modulating Autoimmunity During the Pandemic Era
Abdelhamid, L., & Luo, X. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2021.749774 · Cited by 12
Comment on “A Dynamic Network Model of mTOR Signaling Reveals TSC-Independent mTORC2 Regulation”: Building a Model of the mTOR Signaling Network with a Potentially Faulty Tool
Manning, B. D. (2012) · Science Signaling · doi:10.1126/scisignal.2003250 · Cited by 12
Self-citation
Regulation of Intrinsic and Bystander T Follicular Helper Cell Differentiation and Autoimmunity by Tsc1
Zhang, S., Li, L., Xie, D., Reddy, S., Sleasman, J. W., Ma, L., & Zhong, X. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.620437 · Cited by 12
Contrasting effects of chronic, systemic treatment with mTOR inhibitors rapamycin and metformin on adult neural progenitors in mice
Kusne, Y. N., Goldberg, E. L., Parker, S. S., Hapak, S. M., Maskaykina, I. Y., Chew, W. M., Limesand, K. H., Brooks, H. L., Price, T. J., Sanai, N., et al. (2013) · AGE · doi:10.1007/s11357-013-9572-5 · Cited by 11
Interactome networks between the human respiratory syncytial virus (HRSV), the human metapneumovirus (ΗMPV), and their host: In silico investigation and comparative functional enrichment analysis
Rouka, E. C., Hatzoglou, C., Gourgoulianis, K. I., & Zarogiannis, S. G. (2020) · Microbial Pathogenesis · doi:10.1016/j.micpath.2020.104000 · Cited by 11

Authors: Huang, J., & Manning, B. D.
Affiliations: Harvard University (US)
Corresponding author: Manning, Brendan D.
ORCID: Huang, Jingxiang
Manning, Brendan D.
Venue: Biochemical Society Transactions
Publisher: Portland Press Ltd.
Published: 2009-01-20
Volume: 37
Issue: 1
Pages: 217-222
ISSN: 0300-5127 (ISSN-L)
1470-8752
DOI: 10.1042/bst0370217
PMC: PMC2778026
OpenAlex: W2065322400
Cited by: 724
References: 35
Citations by year: 2026: 17 · 2025: 18 · 2024: 21 · 2023: 22 · 2022: 31 · 2021: 31 · 2020: 37 · 2019: 40 · 2018: 49 · 2017: 40 · 2016: 38 · 2015: 53 · 2014: 60 · 2013: 51 · 2012: 67
FWCI: 5.25
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Locations: Biochemical Society Transactions (publishedVersion)
PubMed (publishedVersion)
PubMed Central (acceptedVersion)
Funders: National Cancer Institute (R01CA122617, P01CA120964)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
Health Sciences › Medicine › Genetics (clinical) › Tuberous Sclerosis Complex Research
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
Keywords: Akt, TSC1/TSC2 complex, tuberous sclerosis complex, mTORC1, mTORC2, PI3K signaling, Rheb, Akt phosphorylation, negative feedback regulation, growth factor signaling, tumor growth
MeSH terms: Tuberous Sclerosis Complex 2 Protein, Animals, Humans, Protein Kinases, Transcription Factors, Phosphatidylinositol 3-Kinases, Feedback, Physiological, Tumor Suppressor Proteins, Proto-Oncogene Proteins c-akt, TOR Serine-Threonine Kinases

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

A complex interplay between Akt, TSC2 and the two mTOR complexes

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks